Omnicell Valuation
| OMCL Stock | USD 33.00 0.72 2.23% |
At this time, the company appears to be undervalued. Omnicell holds a recent Real Value of $39.76 per share. The prevailing price of the company is $33.0. Our model determines the value of Omnicell from analyzing the company fundamentals such as Operating Margin of 0.04 %, return on equity of 0.0103, and Shares Outstanding of 46.76 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Omnicell's price fluctuation is very steady at this time. Calculation of the real value of Omnicell is based on 3 months time horizon. Increasing Omnicell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Omnicell stock is determined by what a typical buyer is willing to pay for full or partial control of Omnicell. Since Omnicell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Omnicell Stock. However, Omnicell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.0 | Real 39.76 | Hype 33.17 | Naive 31.61 |
The intrinsic value of Omnicell's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Omnicell's stock price.
Estimating the potential upside or downside of Omnicell helps investors to forecast how Omnicell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Omnicell more accurately as focusing exclusively on Omnicell's fundamentals will not take into account other important factors: Omnicell Total Value Analysis
Omnicell is now forecasted to have valuation of 1.54 B with market capitalization of 1.54 B, debt of 371.84 M, and cash on hands of 244.95 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Omnicell fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.54 B | 1.54 B | 371.84 M | 244.95 M |
Omnicell Investor Information
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.24. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity had not issued any dividends in recent years. Omnicell is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Omnicell Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Omnicell suggests not a very effective usage of assets in March.Omnicell Ownership Allocation
The majority of Omnicell outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Omnicell to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Omnicell. Please pay attention to any change in the institutional holdings of Omnicell as this could imply that something significant has changed or is about to change at the company.Omnicell Profitability Analysis
The company reported the previous year's revenue of 1.11 B. Net Income was 12.53 M with profit before overhead, payroll, taxes, and interest of 475.51 M.About Omnicell Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Omnicell. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Omnicell based exclusively on its fundamental and basic technical indicators. By analyzing Omnicell's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Omnicell's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Omnicell. We calculate exposure to Omnicell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Omnicell's related companies.Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California. Omnicell operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 4000 people.
Omnicell Growth Indicators
Investing in growth stocks can be very risky. If the company such as Omnicell does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.3 M | |
| Quarterly Earnings Growth Y O Y | 0.558 | |
| Forward Price Earnings | 29.4985 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.